SELLAS Life Sciences Group's total assets for Q3 2024 were $26.50M, an increase of 75.31% from the previous quarter. SLS total liabilities were $10.61M for the fiscal quarter, a -13.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.